Name | a d lh-rh |
---|---|
Synonyms |
GLP-DPHE-TRP-SER-TYR-DALA-LEU-ARG-PRO-GLY-NH2
[D-PHE2,D-ALA6]-LH-RH (HUMAN) PYR-D-PHE-TRP-SER-TYR-D-ALA-LEU-ARG-PRO-GLY-NH2 [D-PHE2,D-ALA6]-LH-RH PGLU-D-PHE-TRP-SER-TYR-D-ALA-LEU-ARG-PRO-GLY-NH2 D-phe2,D-ala6-luteinizing hormone*releasing hormo wy-18,185 LHRH,Phe(2)-Ala(6) (d-phe(sup2))-(d-ala(sup6))-lhrh |
Description | [D-Phe2,D-Ala6]-LH-RH is a potent LH-RH antagonist. [D-Phe2,D-Ala6]-LH-RH shows anti-LH/FSH-RH and antiovulatory activities[1]. |
---|---|
Related Catalog | |
In Vivo | [D-Phe2,D-Ala6]-LH-RH inhibits the LH and FSH release induced by LH-RH in immature male rats[1]. [D-Phe2,D-Ala6]-LH-RH (1 mg/rat, SC) shows marked antiovulatory and contraceptive activity[2].[D-Phe2,D-Ala6]-LH-RH (0.625, 1.25, 2.5 mg/kg; s.c.; single dose; sacrificed 30 minutes) results a dose-dependent increase in stalk-median eminence (SME)-LHRH activity and decreases plasma LHRH activity as well in rats with hypophysectomized (hypox) at 25 days old[3]. [D-Phe2,D-Ala6]-LH-RH (25 mg/kg; s.c.; single dsoe) is effective in blocking the ovulation normally induced by LRH alone[4]. Animal Model: Adult female Sprague-Dawley rats (200-250 g)[2] Dosage: 1 mg/rat Administration: SC injections, from 12:00 to 14:30 hr on the day of proestrus Result: Showed marked antiovulatory and contraceptive activity, with 96% inhibition of ovulation. |
References |
Density | 1.46g/cm3 |
---|---|
Molecular Formula | C59H79N15O13 |
Molecular Weight | 1206.35000 |
Exact Mass | 1205.60000 |
PSA | 443.45000 |
LogP | 2.77280 |
Index of Refraction | 1.687 |
CHEMICAL IDENTIFICATION
HEALTH HAZARD DATAACUTE TOXICITY DATA
|
Risk Phrases | 60 |
---|---|
Safety Phrases | 53-22-36/37/39-45 |